Pharmacokinetics of Loading Dose Vigabatrin Administered via Enteral Tube in Participants With Post-Anoxic Status Epilepticus.
PharmacotherapySep 12, 2026
Nicole F Maranchick, Katharina M Busl, Ralisa Pop et al.
✦ AI-curated · Sources linked
In 30 seconds
This study investigated the pharmacokinetics of loading dose vigabatrin in comatose adults with post-anoxic status epilepticus (PASE) as part of an open-label feasibility trial. Six participants were evaluated, revealing a median elimination half-life of 16.2 hours and maximum concentration of 38.1 mg/L, indicating effective absorption despite critical illness challenges.
Key findings
- Median time to maximum concentration was 2 hours.
- Maximum concentration reached was 38.1 mg/L.
- Median elimination half-life was 16.2 hours.
- Area under the concentration time curve from 0 to 24 hours was 431.2 mg*h/L.
Why it matters
Understanding the pharmacokinetics of vigabatrin in critically ill patients is crucial for optimizing treatment strategies for post-anoxic status epilepticus, a condition with limited therapeutic options.